NEW YORK, August 4, 2021 – FRONTEO (TSE: 2158) announced that our AI review tool "KIBIT Automator" was used for an investigative case of unauthorized access and removal of confidential information in the United States.
Expanded the functions of the AI review tool “KIBIT Automator” which is a key to FRONTEO’s portfolio transformation, enabling one-stop handling of eDiscovery process from pre-processing to document review.
Fronteo hits 6,000 subscriber milestone thanks to variety of video lectures delivered by over one hundred highly acclaimed legal experts in Japan and the U.S.
FRONTEO’s Drug Discovery AI Factory, an AI drug discovery service using unique technologies that discover unreported relationships from published literature, to support target identification and drug repositioning etc.